Results for orphan drug desigation
-
blue-reg.com
BLUE-REG - Consultancy - Regulatory Affairs - Regulatory intelligence/trainings - pharmaco
Welcome to Blue-Reg, a consultancy company specialized in Regulatory Affairs and Pharmacovigilance for the Pharmaceutical Industry.
-
orphan-drug.com
Orphan Drug Market Intelligence by KuicK Research
Orphan Drug Market Intelligence by KuicK Research
-
mwelborngroup.com
Pharmaceutical Consultants - Orphan Approval - New Drug Approval - IND Submission - IND Fa
The M Welborn Group, LLC is a limited liability corporation that provides consultant services to pharmaceutical companies who are seeking to obtain Orphan or New Drug approval including drug application, IND submission and facilitation through the US Food
-
plexius.com
Orphan Drug Launch Services | Plexius Orphan Drug Launch Software for Patient Service Prog
Plexius understands the complexities of an orphan drug launch and the requirements for success. Our services and software save time and money while adapting to your specific needs.
-
agadabio.com
AGADA Biosciences Orphan Drug Development
AGADA Biosciences is a rapidly growing biotech that provides services that accelerate orphan drug development.
-
patarapharma.com
Patara Pharma | Biopharmaceutical Orphan Drug Development
Patara Pharma is a biopharmaceutical company specializing in orphan drug development for immune system diseases including mastocytosis
-
diacomit.us
Diacomit® orphan drug - Stiripentol orphan drug : antiepilectic treatment for dravet synd
Diacomit® orphan drug - stiripentol orphan drug is a dravet syndrome treatment. Diacomit® - stiripentol is to be associeted with valproate and clobazam. Diacomit® has a marketing authorization in Canada, Japan.
-
alepsyr.com
Home : AlepSyr Biotech Consultancy
Biotech Consulting, expert advice and global project management expertise for rare diseases, highly unmet medical needs and orphan drug development.
-
crumblymorsels.com
Siren Interactive | Rare Disease Experts
Siren Interactive is a rare disease marketing agency with a digital focus and unmatched expertise in understanding rare diseases, patients, and orphan drug development.
-
optiollc.com
Optio Biopharma Solutions, LLC | Market Access & Commercialization Services
Commercialization and marketing consulting and support for small biotech and pharma companies. Specialization: - ultra/orphan drug markets - market planning and strategy - linking commercial and specialty drug distribution strategy
-
orphan-iq.com
Home | orphandrugexperts
As a leading expert in Orphan drug development, PSR provides the essential ingredients necessary to help our clients through the logistical and regulatory hurdles which are the hallmark of development programs for rare diseases. In addition to tradit
-
partnersplusgroup.com
Life Sciences | Partners Plus Group | Contract Commercial | commercialization | Orphan Dr
Contract Commercial Organization for the Life Sciences Industry. Experience in rare disease and Orphan Drug commercialization PPG provides a full suite of integrated commercialization services to new and emerging companies. PartnersPlus Group - bring your
-
sireninteractive.com
Siren Interactive | Rare Disease Experts
Siren Interactive is a rare disease marketing agency with a digital focus and unmatched expertise in understanding rare diseases, patients, and orphan drug development.
-
orphan-iq.net
Home | orphandrugexperts
As a leading expert in Orphan drug development, PSR provides the essential ingredients necessary to help our clients through the logistical and regulatory hurdles which are the hallmark of development programs for rare diseases. In addition to tradit
-
orphan-iq.org
Home | orphandrugexperts
As a leading expert in Orphan drug development, PSR provides the essential ingredients necessary to help our clients through the logistical and regulatory hurdles which are the hallmark of development programs for rare diseases. In addition to tradit
-
insmed.com
Insmed Incorporated
Insmed's mission is to improve the treatment of serious orphan diseases through the development of novel, site-specific, inhaled liposomal drug products and to efficiently and effectively move our product candidates through the regulatory approval process
-
orphan-reach.com
orphan reach™- A Rare Disease CROHome - orphan reach™- A Rare Disease CRO
orphan reach is a unique CRO focussed on rare diseases and orphan drugs development. Orphan drugs focus makes it you most suitable partner in you drug development process
-
gliaxal.com
Home - Glioblastoma Medical Food
Medical Food for the special nutritional needs of glioblastoma patients. Designated an orphan drug for the treatment of gliomas.
